Abstract
Human Longevity (HLI) launched Health Nucleus, a genomic-powered clinical research project that the company says has the potential to transform healthcare. The inaugural Health Nucleus facility is located in San Diego at HLI's headquarters. More Health Nucleus facilities are slated to open in 2016 in other U.S. and international cities.
The Health Nucleus platform uses whole-genome sequence analysis, advanced clinical imaging, and machine learning, combined with a comprehensive curation of personal health history, to deliver a comprehensive picture of individual health.
The Health Nucleus provides an approach devoted to exploring, quantifying, and beginning to understand as much as possible about individual health and disease risk, according to J. Craig Venter, Ph.D., co-founder and CEO of HLI. It's supported by the world's largest genome sequencing center and by scientific experts in translating genomics data into clinically relevant information. Dr. Venter points out that it is the first center to combine genomics with a complete array of other clinical and biological measures, including whole human genome sequencing, microbiome sequencing, and metabolome characterization. Also included is a comprehensive body MRI scan to screen for any abnormalities and provide a baseline for the future along with customized laboratory tests and screenings.
Human Longevity, Inc.
“The Health Nucleus is our opportunity to lead the way to genomic health, enabling individuals and their physicians to pivot toward a more proactive, preventative, and predictive healthcare future,” said Dr. Venter.